Relationship of Pathological Factors To Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma

被引：0
|
作者：
Tsuzuki, Toyonori
Araki, Hidemori
Kimura, Tohru
Tanaka, Kuniaki
Yamada, Shin
Sassa, Naoto
Yoshino, Yasushi
Hattori, Ryohei
Gotoh, Momokam
机构：
[1] Japanese Red Cross Nagoya Daini Hosp, Nagoya, Aichi, Japan
[2] Toyohashi Municipal Hosp, Toyohashi, Aichi, Japan
[3] Shakaihoken Chukyo Hosp, Nagoya, Aichi, Japan
[4] Kariya Toyota Gen Hosp, Kariya, Aichi, Japan
[5] Okazaki Municipal Hosp, Okazaki, Aichi, Japan
[6] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[7] Japanese Red Cross Nagoya Daiichi Hosp, Nagoya, Aichi, Japan
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1050
引用
收藏
页码：263A / 264A
页数：2
相关论文
共 50 条
  • [1] Relationship of Pathological Factors To Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma
    Tsuzuki, Toyonori
    Araki, Hidemori
    Kimura, Tohru
    Tanaka, Kuniaki
    Yamada, Shin
    Sassa, Naoto
    Yoshino, Yasushi
    Hattori, Ryohei
    Gotoh, Momokazu
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 263A - 264A
  • [2] Relationship of Pathologic Factors to Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma
    Araki, Hidemori
    Tsuzuki, Toyonori
    Kimura, Tohru
    Tanaka, Kuniaki
    Yamada, Shin
    Sassa, Naoto
    Yoshino, Yasushi
    Hattori, Ryohei
    Gotoh, Momokazu
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (04) : 492 - 499
  • [3] Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis
    Omae, Kenji
    Kondo, Tsunenori
    Kennoki, Takafumi
    Takagi, Toshio
    Iizuka, Junpei
    Kobayashi, Hirohito
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (01) : 126 - 132
  • [4] Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis
    Kenji Omae
    Tsunenori Kondo
    Takafumi Kennoki
    Toshio Takagi
    Junpei Iizuka
    Hirohito Kobayashi
    Yasunobu Hashimoto
    Kazunari Tanabe
    [J]. International Journal of Clinical Oncology, 2016, 21 : 126 - 132
  • [5] A Phase 1 Study of Everolimus and Sorafenib for Metastatic Clear Cell Renal Cell Carcinoma
    Harzstark, Andrea L.
    Small, Eric J.
    Weinberg, Vivian K.
    Sun, Janine
    Ryan, Charles J.
    Lin, Amy M.
    Fong, Lawrence
    Brocks, Dion R.
    Rosenberg, Jonathan E.
    [J]. CANCER, 2011, 117 (18) : 4194 - 4200
  • [6] Sorafenib rechallenge in patients with metastatic renal cell carcinoma
    Nozawa, Masahiro
    Yamamoto, Yutaka
    Minami, Takafumi
    Shimizu, Nobutaka
    Hatanaka, Yuji
    Tsuji, Hidenori
    Uemura, Hirotsugu
    [J]. BJU INTERNATIONAL, 2012, 110 (6B) : E228 - E234
  • [7] Impact of β-adrenergic blockade on efficacy of immunotherapy in patients with metastatic clear cell renal cell carcinoma
    Semaan, Karl
    Eid, Marc
    Saad, Eddy
    Issa, Wadih
    Saliby, Renee Maria
    Paul, Morgan
    Zhong, Caiwei
    Gunenc, Damla
    Phillips, Noa
    Nawfal, Rashad
    Machaalani, Marc
    Chehade, Razane El Hajj
    Yekeduz, Emre
    Labaki, Chris
    El Zarif, Talal
    Baca, Sylvan C.
    Xie, Wanling
    McGregor, Bradley Alexander
    Zhang, Tian
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Cardiac involvement in patients with sorafenib or sunitinib treatment for metastatic renal cell carcinoma
    Schmidinger, M.
    Vogl, U. M.
    Schukro, C.
    Bojic, A.
    Bojic, M.
    Schmidinger, H.
    Zielinski, C. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
    Schlemmer, Marcus
    Spek, Annabel
    Rodler, Severin
    Schott, Melanie
    Casuscelli, Jozefina
    Staehler, Michael
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (03)
  • [10] Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
    Xu K.Y.
    Wu S.
    [J]. Biomarker Research, 3 (1)
12345